Tuesday - September 22, 2026
Response to Neoadjuvant Immunochemotherapy May Allow for Surgical De-escalation in Head and Neck Cancers
September 10, 2026
PHILADELPHIA, Pennsylvania, Sept. 10 [Category: Medical] -- The American Association for Cancer Research posted the following news release:

* * *

Response to Neoadjuvant Immunochemotherapy May Allow for Surgical De-escalation in Head and Neck Cancers

Surgery often results in organ dysfunction and facial disfigurement

-

Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors responded to neoadjuvant . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products